{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:12:18Z","timestamp":1792858338989,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1093\/jac\/dkp401","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T02:17:43Z","timestamp":1257387463000},"page":"91-97","source":"Crossref","is-referenced-by-count":49,"title":["bro \u03b2-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults"],"prefix":"10.1093","volume":"65","author":[{"given":"Mushtaq A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Blackman","family":"Northwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foster","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J. C.","family":"Verhaegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Van Belkum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,11,4]]},"reference":[{"key":"key\n\t\t\t\t20170425175657_DKP401C1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1128\/CMR.15.1.125-144.2002","article-title":"Moraxella catarrhalis: from emerging to established pathogen","volume":"15","author":"Verduin","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20170425175657_DKP401C2","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/0-387-30746-X_38","article-title":"The genus Moraxella","volume-title":"The Prokaryotes","author":"Hays","year":"2006","edition":"3rd edn"},{"key":"key\n\t\t\t\t20170425175657_DKP401C3","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1128\/AAC.33.11.1845","article-title":"BRO \u03b2-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal \u03b2-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata","volume":"33","author":"Wallace","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425175657_DKP401C4","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1099\/mic.0.2007\/015057-0","article-title":"Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001\u20132002","volume":"154","author":"Verhaegh","year":"2008","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20170425175657_DKP401C5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jac\/3.4.374","article-title":"In vitro sensitivity to penicillin V and \u03b2-lactamase production of Branhamella catarrhalis","volume":"3","author":"Malmvall","year":"1977","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425175657_DKP401C6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.diagmicrobio.2005.05.004","article-title":"Antimicrobial activity of tigecycline tested against organisms causing community\u2014acquired respiratory tract infection and nosocomial pneumonia","volume":"52","author":"Fritsche","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425175657_DKP401C7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0732-8893(03)00089-0","article-title":"Susceptibility trends of Haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program","volume":"47","author":"Johnson","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425175657_DKP401C8","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1128\/JCM.00456-06","article-title":"Contemporary prevalence of BRO \u03b2-lactamases in Moraxella catarrhalis: report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004)","volume":"44","author":"Deshpande","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170425175657_DKP401C9","doi-asserted-by":"crossref","first-page":"ii97","DOI":"10.1093\/jac\/dkn356","article-title":"Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999\u20132007","volume":"62","author":"Morrissey","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425175657_DKP401C10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01962070","article-title":"Characterization of cell-bound papain-soluble \u03b2-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens","volume":"11","author":"Eliasson","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425175657_DKP401C11","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/AAC.40.4.966","article-title":"Molecular characterization of the BRO \u03b2-lactamase of Moraxella (Branhamella) catarrhalis","volume":"40","author":"Bootsma","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425175657_DKP401C12","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1128\/JB.181.16.5090-5093.1999","article-title":"Moraxella (Branhamella) catarrhalis BRO \u03b2-lactamase: a lipoprotein of gram-positive origin?","volume":"181","author":"Bootsma","year":"1999","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20170425175657_DKP401C13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2958.2000.01828.x","article-title":"Genesis of BRO \u03b2-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer","volume":"36","author":"Bootsma","year":"2000","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20170425175657_DKP401C14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/dkh063","article-title":"BRO \u03b2-lactamase alleles, antibiotic resistance and a test of the BRO-1 selective replacement hypothesis in Moraxella catarrhalis","volume":"53","author":"Levy","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425175657_DKP401C15","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/infdis\/170.6.1613","article-title":"Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia","volume":"170","author":"Hol","year":"1994","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170425175657_DKP401C16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003495-198600313-00020","article-title":"Branhamella catarrhalis as an indirect pathogen","volume":"31","author":"Wardle","year":"1986","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170425175657_DKP401C17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkf807","article-title":"The need for antimicrobial resistance surveillance","volume":"50","author":"Felmingham","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425175657_DKP401C18","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically\u2014Fifth Edition: Approved Standard M7-A5","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"key\n\t\t\t\t20170425175657_DKP401C19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1348-0421.2007.tb03904.x","article-title":"Colonization and turnover of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in otitis-prone children","volume":"51","author":"Yokota","year":"2007","journal-title":"Microbiol Immunol"},{"key":"key\n\t\t\t\t20170425175657_DKP401C20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10156-005-0421-Z","article-title":"Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1\u20133 (1999\u20132002)","volume":"12","author":"Inoue","year":"2006","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20170425175657_DKP401C21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/1120009X.2004.11782403","article-title":"Resistance trends in Moraxella catarrhalis (PROTEKT years 1\u20133 [1999\u20132002])","volume":"16","author":"Canton","year":"2004","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20170425175657_DKP401C22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/38.suppl_A.85","article-title":"Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in western Europe and in the USA. The Alexander Project Collaborative Group","volume":"38","author":"Berk","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425175657_DKP401C23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1469-0691.2007.01776.x","article-title":"Evaluation of susceptibility patterns and BRO \u03b2-lactamase types among clinical isolates of Moraxella catarrhalis","volume":"13","author":"Esel","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170425175657_DKP401C24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1471-2180-9-188","article-title":"Outer membrane porin M35 of Moraxella catarrhalis mediates susceptibility to aminopenicillins","volume":"9","author":"Jetter","year":"2009","journal-title":"BMC Microbiol"},{"key":"key\n\t\t\t\t20170425175657_DKP401C25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0924-8579(03)00158-4","article-title":"Correlation between susceptibility and BRO type enzyme of Moraxella catarrhalis strains","volume":"22","author":"Kadry","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170425175657_DKP401C26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/45.2.175","article-title":"Long-term trends in susceptibility of Moraxella catarrhalis: a population analysis","volume":"45","author":"Walker","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425175657_DKP401C27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000077889","article-title":"Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the ketolide telithromycin: results from the PROTEKT surveillance study (1999\u20132000)","volume":"50","author":"Reinert","year":"2004","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20170425175657_DKP401C28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998\u20132000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425175657_DKP401C29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1590\/S1413-86702003000100006","article-title":"Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999\u20132000)","volume":"7","author":"Mendes","year":"2003","journal-title":"Braz J Infect Dis"},{"key":"key\n\t\t\t\t20170425175657_DKP401C30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01699978","article-title":"Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO \u03b2-lactamases","volume":"17","author":"McGregor","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425175657_DKP401C31","first-page":"956","article-title":"Guidelines for the use of antibiotics in acute upper respiratory tract infections","volume":"74","author":"Wong","year":"2006","journal-title":"Am Fam Physician"},{"key":"key\n\t\t\t\t20170425175657_DKP401C32","article-title":"Increasing prevalence of \u03b2-lactam resistant Haemophilus influenza in Japan: in vitro activity of telithromycin and \u03b2-lactam antimicrobials over 4 years","author":"Baba"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/65\/1\/91\/13759439\/dkp401.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T12:13:01Z","timestamp":1590235981000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkp401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,11,4]]},"published-print":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkp401","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11,4]]}}}